Karachi: LSE Capital Limited (LSECL) has announced a significant strategic move to enter into a joint venture with LABLINK Enterprises, a sole proprietorship dealing in the import, distribution, and supply of medical, healthcare, and surgical products. The decision was made through a resolution by circulation approved by the Board of LSECL, as per a report dated November 5, 2026.

The joint venture aims to participate in the pre-qualification and bidding process for a project in the province of Sindh. LABLINK Enterprises has established itself as a key player in the medical supplies sector, dealing with products from multinational principals such as NIPRO and Baxter.

According to information available from the Pakistan Stock Exchange (PSX), this collaboration marks a strategic step for LSECL as it seeks to expand its footprint in the healthcare sector. The market response to this announcement will be closely monitored, given the potential implications for both companies in the designated market category.

The move reflects LSECL's commitment to leveraging industry collaborations for growth and aligning with established partners to enhance service delivery in the medical supplies domain.